LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
3.77 / 10
Netural
Analyst sentiment is limited: one Buy recommendation from Citizens with a 0% win rate and –22.86% average return. Fund‑flow metrics score 7.55/10, showing moderate overall inflow (45%) and positive medium‑size investor flow, but negative trends for block, small, large and extra‑large investors. Caution advised.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-09
InstitutionCitizens
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for LYEL?
- LYEL holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.77/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
